In contrast to previous reports utilizing cell lines, our data show that the synthetic GPR43 antagonist is an effective blocker of GPR43 on IECs in vitro and in GVHD vivo (Supplementary Fig. 5)30. This evidence concerns the gene FFAR2 and graft versus host disease.